Silencing Inflammation: Nano-Antioxidants and Immunomodulators in PCOS Management
July 2025
nanotechnology polycystic ovary syndrome PCOS metal nanoparticles biocompatible nanocarriers oxidative stress insulin sensitivity hormone levels curcumin quercetin resveratrol follicular maturation metabolic regulation immunomodulatory nanoparticles chronic inflammation immune pathways adipose tissue nano-antioxidants immune pathways in fat tissue
Studysummary This chapter discusses how nanotechnology, through the use of metal nanoparticles and biocompatible carriers, along with antioxidants like curcumin, quercetin, and resveratrol, offers promising approaches for treating PCOS by reducing oxidative stress and inflammation, enhancing insulin sensitivity, and normalizing hormone levels.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The document discusses the potential of nanotechnology in managing polycystic ovary syndrome (PCOS), a condition affecting over 116 million women worldwide. It highlights the use of metal nanoparticles and biocompatible nanocarriers to deliver drugs that reduce oxidative stress, enhance insulin sensitivity, and normalize hormone levels. Antioxidants such as curcumin, quercetin, and resveratrol are noted for supporting follicular maturation and metabolic regulation, contributing to long-term reproductive health. Additionally, immunomodulatory nanoparticles can mitigate chronic inflammation through immune pathways in adipose tissue. The chapter emphasizes the role of nanotechnology in addressing the inflammatory and immunological aspects of PCOS.
